SETIAWAN SI, ASCOBAT P. ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA. Int J App Pharm [Internet]. 2019 Dec. 15 [cited 2024 Nov. 21];11(6):80-3. Available from: https://journals.innovareacademics.in/index.php/ijap/article/view/33551